![Dr. Cerchietti Receives Doris Duke Clinical Scientist Award for Study of B-Cell Lymphoma | Weill Department of Medicine Dr. Cerchietti Receives Doris Duke Clinical Scientist Award for Study of B-Cell Lymphoma | Weill Department of Medicine](https://medicine.weill.cornell.edu/sites/default/files/styles/panopoly_image_quarter/public/profile_images/cerchietti-leandro.jpg?itok=4c2d9BmY)
Dr. Cerchietti Receives Doris Duke Clinical Scientist Award for Study of B-Cell Lymphoma | Weill Department of Medicine
![Effect of topical morphine for mucositis‐associated pain following concomitant chemoradiotherapy for head and neck carcinoma - Cerchietti - 2002 - Cancer - Wiley Online Library Effect of topical morphine for mucositis‐associated pain following concomitant chemoradiotherapy for head and neck carcinoma - Cerchietti - 2002 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/208022fc-4954-4349-8789-2d35f80f4272/cncr.v129.21.cover.jpg?trick=1697407779299)
Effect of topical morphine for mucositis‐associated pain following concomitant chemoradiotherapy for head and neck carcinoma - Cerchietti - 2002 - Cancer - Wiley Online Library
![PDF) Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas PDF) Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas](https://i1.rgstatic.net/publication/51052731_Inhibition_of_Anaplastic_Lymphoma_Kinase_ALK_Activity_Provides_a_Therapeutic_Approach_for_CLTC-ALK-Positive_Human_Diffuse_Large_B_Cell_Lymphomas/links/0deec51e95a707cda0000000/largepreview.png)